Budesonide to remain script only for asthma: TGA
The bid, by an unknown applicant, was rejected this month
The TGA has knocked back a proposal to make budesonide available over the counter for asthma, saying it would not curb the overuse of salbutamol.
The watchdog has not revealed who bid to downschedule the inhaled corticosteroid, but the RACGP, the AMA and patient group Asthma Australia all criticised the proposal when it was put forward in June.
